BHC
Price
$5.98
Change
+$0.47 (+8.53%)
Updated
Jun 13 closing price
Capitalization
3.86B
45 days until earnings call
SXTC
Price
$1.83
Change
-$0.21 (-10.29%)
Updated
Jun 13 closing price
Capitalization
950.1K
Interact to see
Advertisement

BHC vs SXTC

Header iconBHC vs SXTC Comparison
Open Charts BHC vs SXTCBanner chart's image
Bausch Health Companies
Price$5.98
Change+$0.47 (+8.53%)
Volume$11.5M
Capitalization3.86B
China SXT Pharmaceuticals
Price$1.83
Change-$0.21 (-10.29%)
Volume$57.71K
Capitalization950.1K
BHC vs SXTC Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. SXTC commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and SXTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (BHC: $5.98 vs. SXTC: $1.83)
Brand notoriety: BHC: Notable vs. SXTC: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 476% vs. SXTC: 1%
Market capitalization -- BHC: $3.86B vs. SXTC: $950.1K
BHC [@Pharmaceuticals: Other] is valued at $3.86B. SXTC’s [@Pharmaceuticals: Other] market capitalization is $950.1K. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileSXTC’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • SXTC’s FA Score: 0 green, 5 red.
According to our system of comparison, BHC is a better buy in the long-term than SXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 5 TA indicator(s) are bullish while SXTC’s TA Score has 2 bullish TA indicator(s).

  • BHC’s TA Score: 5 bullish, 4 bearish.
  • SXTC’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, BHC is a better buy in the short-term than SXTC.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а +25.63% price change this week, while SXTC (@Pharmaceuticals: Other) price change was -12.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

BHC is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than SXTC($950K). BHC has higher P/E ratio than SXTC: BHC (13.39) vs SXTC (0.03). BHC YTD gains are higher at: -25.806 vs. SXTC (-54.979). BHC has higher annual earnings (EBITDA): 2.2B vs. SXTC (-5.36M). SXTC has less debt than BHC: SXTC (3.76M) vs BHC (22.4B). BHC has higher revenues than SXTC: BHC (8.76B) vs SXTC (1.97M).
BHCSXTCBHC / SXTC
Capitalization3.86B950K406,211%
EBITDA2.2B-5.36M-41,102%
Gain YTD-25.806-54.97947%
P/E Ratio13.390.0339,065%
Revenue8.76B1.97M444,067%
Total Cash947MN/A-
Total Debt22.4B3.76M596,220%
FUNDAMENTALS RATINGS
BHC vs SXTC: Fundamental Ratings
BHC
SXTC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5065
P/E GROWTH RATING
1..100
9885
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for SXTC (68) in the Pharmaceuticals Major industry. This means that BHC’s stock grew somewhat faster than SXTC’s over the last 12 months.

BHC's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SXTC (100) in the Pharmaceuticals Major industry. This means that BHC’s stock grew similarly to SXTC’s over the last 12 months.

SXTC's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that SXTC’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as SXTC (65) in the Pharmaceuticals Major industry. This means that BHC’s stock grew similarly to SXTC’s over the last 12 months.

SXTC's P/E Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as BHC (98) in the Pharmaceuticals Other industry. This means that SXTC’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCSXTC
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MEAR50.140.01
+0.01%
iShares Short Maturity Muni Bd Act ETF
WWJD33.98-0.34
-0.99%
Inspire International ETF
NOBL99.79-1.30
-1.29%
ProShares S&P 500 Dividend Aristocrats
TMFX19.51-0.37
-1.87%
Motley Fool Next ETF
PGJ28.18-0.80
-2.76%
Invesco Golden Dragon China ETF

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and PAHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and PAHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+8.53%
PAHC - BHC
26%
Poorly correlated
-2.37%
ZTS - BHC
26%
Poorly correlated
-2.66%
TEVA - BHC
26%
Poorly correlated
-4.07%
OGI - BHC
26%
Poorly correlated
-4.76%
TLRY - BHC
26%
Poorly correlated
-2.95%
More

SXTC and

Correlation & Price change

A.I.dvisor tells us that SXTC and AYTU have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and AYTU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
-10.29%
AYTU - SXTC
28%
Poorly correlated
N/A
CPHI - SXTC
26%
Poorly correlated
+2.52%
BGM - SXTC
25%
Poorly correlated
-13.52%
CHSYF - SXTC
23%
Poorly correlated
N/A
BHC - SXTC
21%
Poorly correlated
+8.53%
More